Sudarshan Pharma Industries Limited
Issue of Securities
01 / The disclosure
What the company shared
Sudarshan Pharma Industries Limited has informed the Exchange about issue of Securities - In continuation of the Company''s letter dated 30/Oct/2026 (ref. no. SPIL/CS/2026-2027/72), the Board of Directors at its Meeting held on 29/Oct/2026 have approved the proposal to raising of funds through issue and allotment of Convertible Warrants upto an amount not exceeding Rs.72 Crores, each warrant convertible into 1 equity share of Re1/- each, on a preferential basis to Mr. Hemal Mehta and Mr. Sachin Mehta, Promoters of the Company. The Warrants shall be issued at a price to be determined as per Regulation 164 of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.
A question for your research
Check transaction size, funding, dilution, approvals and completion conditions before assessing the earnings impact.
The evidence
Read the source excerpts
PDF text is unavailable. Read the original filing for the full disclosure.
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106837488
- First collected
- 30 Oct 2026, 20:48 IST
- PDF extraction
- metadata_only